Fayette County Clinic:
Washington CH, Ohio

Phone 740-335-6935
Crisis 740-335-7155

Floyd Simantel Clinic:
Chillicothe, Ohio

Phone 740-775-1270
Crisis 740-773-4357

Highland County Clinic:
Hillsboro, Ohio

Phone 937-393-9946
Crisis 937-393-9904

Lynn Goff Clinic:
Greenfield, Ohio

Phone 937-981-7701
Crisis 937-393-9904

Martha Cottrill Clinic:
Chillicothe, Ohio

Phone 740-775-1260
Crisis 740-773-4357

Pickaway County Clinic:
Circleville, Ohio

Phone 740-474-8874
Crisis 740-477-2579

Pike County Clinic:
Waverly, Ohio

Phone 740-947-7783
Crisis 740-947-2147



powered by centersite dot net
Basic InformationLatest News
When Reconstructing a Breast, Patient's Own Tissue Is BestVitamin D May Guard Against Colon CancerStrategies to Avoid SunburnLiver Cancer a Big Threat to U.S., Other Developed NationsChildhood Cancer Impacts Mental HealthBalanced Diet May Be Key to Cancer SurvivalAntiviral Treatments Reduce Cancer Risk for HIV PatientsNew DNA Test May Predict Prostate Cancer Risk1st 'Biosimilar' OK'd to Prevent Chemo-Related InfectionsBreakthrough Therapy Seems to Rid Woman of Advanced Breast CancerDrug May Spare Some Kidney Cancer Patients From Organ RemovalNew Treatments May Extend Pancreatic Cancer SurvivalCancer Drug Keytruda a New Weapon Against Advanced Lung TumorsGene Test May Allow Many With Early Breast Cancer to Avoid ChemoExperimental Drug Shows 'Modest' Benefit in Slowing Advanced Breast CancerBlacks With Prostate Cancer May Fare Better Than WhitesCancer Care Twice as Costly in U.S. Versus CanadaMany Breast Cancer Survivors Not Getting Needed Mammograms'Face-Aging' Photos Convince Tanners to Shun the SunAI Better Than Docs at Catching Skin CancersWidely Used Antibacterial Tied to Colon Woes in MiceNew Guidelines Lower Colon Cancer Screening Age to 45Thyroid Cancer Survivors at Risk for Heart DiseaseHow to Do a Self-Check for Skin CancerAnother Foe for the U.S. Military: Skin CancerLow-Fat Diet Tied to Better Breast Cancer SurvivalHeavier Women May Face Higher Cancer Risks, Study FindsLung Cancer Incidence Higher for Young Women Than Young MenSurveillance Frequency Doesn't Cut Mortality in Colorectal CancerFrom 2008 to 2014, Prostate Cancer Testing, Treatment DownU.S. Cancer Death Rate Declines Again, But Prostate Cancer Incidence RisesBreath Test Shows Promise for Diagnosis of Esophagogastric CADilemma for Cancer Patients as Life-Saving Meds Are Tied to Vision LossGood Evidence That HPV Vaccines Protect Against Cervical PrecancerMen May Gain More From Cancer ImmunotherapyBreast Cancer Patients May Shorten Herceptin Regimen: StudyToo Few Smokers Get Lifesaving Lung Cancer TestsColon Polyp Type May Be Key to Cancer RiskPeripheral Neuropathy Common in Childhood Cancer SurvivorsRisk Models Help Select Ever Smokers for Lung CA ScreeningWhat Causes Cancer? Misconceptions AboundTeledermatology Could Expedite Care for Suspected Skin CancerCKAP4 Is Novel Serodiagnostic Marker for Lung CancerMany Oncologists Discuss, Recommend Medical MarijuanaCancer Docs: We Need More Research on Medical MarijuanaLymphoma, Leukemia Survivors Have Increased Health Care UseChronic Aspirin Exposure Linked to Melanoma Risk in MalesLong-Term Cardiovascular Risk for Endometrial Cancer SurvivorsType 2 Diabetes Ups Risk of Renal Cancer in Women, but Not MenExpert Panel Highlights Patient Choice for Prostate Cancer Screen
VideosLinksBook ReviewsSelf-Help Groups
Related Topics

Medical Disorders
Pain Management

Childhood Cancer Impacts Mental Health

HealthDay News
by -- Robert Preidt
Updated: Jun 13th 2018

new article illustration

WEDNESDAY, June 13, 2018 (HealthDay News) -- Children with neuroblastoma, a pediatric cancer of nerve cells, are vulnerable to mental health and behavioral problems, a new study finds.

Neuroblastoma is diagnosed at a median age of 17.3 months. Treatment advances have prolonged survival for many patients, the study authors said.

This study included 859 children younger than 18 who had been diagnosed with neuroblastoma at least five years earlier. Their median age at diagnosis was 0.8 years and they were followed for a median of 13.3 years.

The neuroblastoma survivors were compared with 872 siblings of childhood cancer survivors.

The neuroblastoma patients were more likely than the siblings to have anxiety/depression (19 percent vs. 14 percent), headstrong behavior (19 percent vs. 13 percent), attention deficits (21 percent vs. 13 percent), peer conflict/social withdrawal (26 percent vs. 17 percent), and antisocial behavior (16 percent vs. 12 percent).

"These findings are novel because this is the first large study that could look at how neuroblastoma patients are doing in terms of psychological and educational outcomes. Before recent advances in treatment, this survivor population was much smaller and we were not able to analyze these sorts of long-term outcomes," said study author Dr. Nina Kadan-Lottick, from Yale University School of Medicine.

The common treatments for neuroblastoma -- vincristine, cisplatin and retinoic acid -- were not associated with these problems. But survivors who developed chronic health conditions as a result of their cancer treatment were at increased risk for the mental health/behavioral issues, the researchers said.

Specifically, pulmonary disease was linked with an increased risk of all five problems, and endocrine disease and peripheral neuropathy were each linked with increased risk of three of the problems.

The researchers also found that neuroblastoma survivors who developed mental health/behavioral problems tended to require special education services and to not go on to college.

The study results were published online June 11 in the journal Cancer.

"Our hope is that these findings will help inform strategies for early screening and intervention to identify those survivors at highest risk for developing psychological and educational impairment later on in life," Kadan-Lottick said in a journal news release.

More information

The U.S. National Cancer Institute has more on neuroblastoma.